Rapid Novor is a Kitchener, Ontario-based antibody discovery and characterization CRO that employs advanced mass spectrometry to achieve unparalleled precision in de novo antibody sequencing. Their proprietary technology platform enables rapid, accurate determination of antibody sequences directly from protein samples, supporting therapeutic antibody development, biosimilar characterization, and intellectual property protection.